Inventor
Jae Yang Kong
Inventor
Daejeon, KR
Overview
Patents· 18 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds34%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations32%
A61KPreparations for medical, dental or toiletry purposes12%
C07CAcyclic or carbocyclic compounds5%
H01MProcesses or means, e.g. batteries, for the direct conversion of chemical energy into electrical energy5%
Y02EReduction of greenhouse gas [ghg] emissions, related to energy generation, transmission or distribution5%
B08BCleaning in general2%
B65HHandling thin or filamentary material, e.g. sheets, webs, cables2%
Y02PClimate change mitigation technologies in the production or processing of goods2%
PatentTitleYear
10,978,759Battery module having improved cooling performance202110,974,285Device comprising cleaning roll and for cleaning protective film for preparing battery cell20219,655,916'Compositions for external application, containing adenosylcobalamin for improvement of skin diseases'20178,598,173'1-[(6,7-substituted alkoxyquinoxalinyl)aminocarbonyl]-4-(hetero)arylpiperazine derivatives for treating tumors'20138,372,844'Piperazinyl-propyl-pyrazole derivatives as dopamine D4 receptor antagonists, and pharmaceutical compositions containing the same'20138,314,100'1-[6,7-substituted alkoxyquinoxalinyl)aminocarbonyl]-4-(hetero)arylpiperazine derivatives'20128,236,806'Piperazinyl-propyl-pyrazole derivatives as dopamine D4 receptor antagonists, and pharmaceutical compositions containing the same'20127,915,405'2,4-disubstituted-5-aminocarbonyl-1,3-thiazole derivatives for therapeutic agent of antiinflammatory disease, method thereof for preparation, therapeutic agent for antiinflammatory disease induced by SPC activity containing the same'20117,662,810'2-arylmethylazetidine carbapenem derivatives and preparation thereof'20107,078,407'4-hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them'20067,009,053'Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition comprising the same'20066,759,419'Pyrrolidinone derivatives, their preparation and pharmaceutical composition comprising the same'20046,723,724'Isoxazolylalkylpiperazine derivatives having selective biological activity at dopamine D3 or D4 receptor, and preparation thereof'20046,716,857'Tetrahydropyridine derivatives acting on muscarinic acetylcholine receptors'20046,673,800'4,5,-dihydroisoxazolylakylpiperazine derivatives having selective biological activity at dopamine D3 or D4 receptor, and preparation thereof'20045,990,126'Quinolinic sulfide derivatives acting as NMDA receptor antagonists and process for preparation thereof'19995,973,201'Phenylacetamide derivatives'19995,409,933'Quinoline derivatives and processes for preparing the same'1995Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1995–2021Based in Daejeon, KR· patent location history
1999–2013Patents assigned to KOREA RES INST CHEM TECH (12)· patent assignee history
1999Based in Yongin-si, KR· patent location history
2004Patents assigned to KOREA INST SCI & TECH (4)· patent assignee history
2011–2021Based in Seoul, KR· patent location history
2012–2013Patents assigned to KONG JAE YANG (3)· patent assignee history
2012–2013Patents assigned to CHA JOO HWAN (2)· patent assignee history
2012–2013Patents assigned to CHAE SANG EUN (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| KOREA RES INST CHEM TECH | 12 | 1999–2013 |
| KOREA INST SCI & TECH | 4 | 2004 |
| KONG JAE YANGself | 3 | 2012–2013 |
| CHA JOO HWAN | 2 | 2012–2013 |
| CHAE SANG EUN | 2 | 2012–2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Daejeon, KR | 13 | 1995–2021 |
| Seoul, KR | 4 | 2011–2021 |
| Yongin-si, KR | 1 | 1999 |